217 related articles for article (PubMed ID: 20089518)
1. Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Trendelenburg M; Theroux P; Stebbins A; Granger C; Armstrong P; Pfisterer M
Eur Heart J; 2010 May; 31(10):1181-7. PubMed ID: 20089518
[TBL] [Abstract][Full Text] [Related]
2. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.
; Armstrong PW; Granger CB; Adams PX; Hamm C; Holmes D; O'Neill WW; Todaro TG; Vahanian A; Van de Werf F
JAMA; 2007 Jan; 297(1):43-51. PubMed ID: 17200474
[TBL] [Abstract][Full Text] [Related]
3. Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Welsh RC; Granger CB; Westerhout CM; Blankenship JC; Holmes DR; O'Neill WW; Hamm CW; Van de Werf F; Armstrong PW;
JACC Cardiovasc Interv; 2010 Mar; 3(3):343-51. PubMed ID: 20298996
[TBL] [Abstract][Full Text] [Related]
4. Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes.
Guptill JT; Mehta RH; Armstrong PW; Horton J; Laskowitz D; James S; Granger CB; Lopes RD
Circ Cardiovasc Interv; 2013 Apr; 6(2):176-83. PubMed ID: 23549644
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.
Bagai A; Armstrong PW; Stebbins A; Mahaffey KW; Hochman JS; Weaver WD; Patel MR; Granger CB; Lopes RD
Am Heart J; 2013 Nov; 166(5):913-9. PubMed ID: 24176448
[TBL] [Abstract][Full Text] [Related]
6. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
[TBL] [Abstract][Full Text] [Related]
7. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.
Granger CB; Mahaffey KW; Weaver WD; Theroux P; Hochman JS; Filloon TG; Rollins S; Todaro TG; Nicolau JC; Ruzyllo W; Armstrong PW;
Circulation; 2003 Sep; 108(10):1184-90. PubMed ID: 12925454
[TBL] [Abstract][Full Text] [Related]
8. Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
Armstrong PW; Fu Y; Westerhout CM; Hudson MP; Mahaffey KW; White HD; Todaro TG; Adams PX; Aylward PE; Granger CB
J Am Coll Cardiol; 2009 Apr; 53(17):1503-9. PubMed ID: 19389560
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Tjandrawidjaja MC; Fu Y; Westerhout CM; Wagner GS; Granger CB; Armstrong PW;
Am J Cardiol; 2010 Sep; 106(5):630-4. PubMed ID: 20723636
[TBL] [Abstract][Full Text] [Related]
10. Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction.
Cheng JM; van Leeuwen MA; de Boer SP; Wai MC; den Uil CA; Jewbali LS; van Geuns RJ; Kardys I; van Domburg RT; Boersma E; Zijlstra F; Akkerhuis KM
Int J Cardiol; 2013 Oct; 168(4):3758-63. PubMed ID: 23830073
[TBL] [Abstract][Full Text] [Related]
11. Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Alhadramy O; Westerhout CM; Brener SJ; Granger CB; Armstrong PW;
Am Heart J; 2010 May; 159(5):899-904. PubMed ID: 20435202
[TBL] [Abstract][Full Text] [Related]
12. Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".
French JK; Armstrong PW; Cohen E; Kleiman NS; O'Connor CM; Hellkamp AS; Stebbins A; Holmes DR; Hochman JS; Granger CB; Mahaffey KW
Am Heart J; 2011 Jul; 162(1):89-97. PubMed ID: 21742094
[TBL] [Abstract][Full Text] [Related]
13. Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
Hudson MP; Armstrong PW; O'Neil WW; Stebbins AL; Weaver WD; Widimsky P; Aylward PE; Ruzyllo W; Holmes D; Mahaffey KW; Granger CB
Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):183-92. PubMed ID: 21304097
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial.
Zeymer U; Tebbe U; Weber M; Vohringer HF; Jaksch R; Bischoff KO; Toepel W; Marsalek P; Horn S; Neuhaus KL;
J Invasive Cardiol; 2003 Jul; 15(7):385-9. PubMed ID: 12840235
[TBL] [Abstract][Full Text] [Related]
15. Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Martel C; Granger CB; Ghitescu M; Stebbins A; Fortier A; Armstrong PW; Bonnefoy A; Theroux P
Am Heart J; 2012 Jul; 164(1):43-51. PubMed ID: 22795281
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.
Lincoff AM; Roe M; Aylward P; Galla J; Rynkiewicz A; Guetta V; Zelizko M; Kleiman N; White H; McErlean E; Erlinge D; Laine M; Dos Santos Ferreira JM; Goodman S; Mehta S; Atar D; Suryapranata H; Jensen SE; Forster T; Fernandez-Ortiz A; Schoors D; Radke P; Belli G; Brennan D; Bell G; Krucoff M;
Eur Heart J; 2014 Oct; 35(37):2516-23. PubMed ID: 24796339
[TBL] [Abstract][Full Text] [Related]
17. Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention.
Haahr-Pedersen S; Bjerre M; Flyvbjerg A; Mogelvang R; Dominquez H; Hansen TK; Galatius S; Bech J; Madsen JK; Søgaard P; Jensen JS
J Invasive Cardiol; 2009 Jan; 21(1):13-9. PubMed ID: 19126922
[TBL] [Abstract][Full Text] [Related]
18. Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Westerhout CM; Pieper KS; James SK; Mahaffey KW; de Werf FV; Califf RM; Granger CB; Armstrong PW
Am Heart J; 2013 Mar; 165(3):354-62.e2. PubMed ID: 23453104
[TBL] [Abstract][Full Text] [Related]
19. Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Koul S; Smith JG; Scherstén F; James S; Lagerqvist B; Erlinge D
Eur Heart J; 2011 Dec; 32(23):2989-97. PubMed ID: 21719452
[TBL] [Abstract][Full Text] [Related]
20. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.
Abdel-Wahab M; Saad M; Kynast J; Geist V; Sherif MA; Richardt G; Toelg R
Am J Cardiol; 2010 Apr; 105(7):967-71. PubMed ID: 20346314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
